Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model

被引：0
|
作者：
Rupsha Mondal
Chayan Banerjee
Sumangal Nandy
Moumita Roy
Joy Chakraborty
机构：
[1] CSIR-Indian Institute of Chemical Biology,
[2] Academy of Scientific and Innovative Research (AcSIR),undefined
来源：
Cell & Bioscience | / 13卷
关键词：
Dopamine toxicity; Mitochondrial fragmentation; Calcineurin; Parkinson’s disease; L-DOPA therapy; Dendritic spine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson's disease model
    Mondal, Rupsha
    Banerjee, Chayan
    Nandy, Sumangal
    Roy, Moumita
    Chakraborty, Joy
    CELL AND BIOSCIENCE, 2023, 13 (01):
  • [2] Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease
    Paul, Rajib
    Phukan, Banashree Chetia
    Thenmozhi, Arokiasamy Justin
    Manivasagam, Thamilarasan
    Bhattacharya, Pallab
    Borah, Anupom
    LIFE SCIENCES, 2018, 192 : 238 - 245
  • [3] DJ-1 Protects Against Dopamine Toxicity: Implications for Parkinson's Disease and Aging
    Lev, Nirit
    Barhum, Yael
    Pilosof, Neri S.
    Ickowicz, Debby
    Cohen, Haim Y.
    Melamed, Eldad
    Offen, Daniel
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2013, 68 (03): : 215 - 225
  • [4] VIP protects from dopamine toxicity: relevance for Parkinson's disease
    Offen, D
    Melamed, E
    Fridkin, M
    Brenneman, DE
    Gozes, I
    BRAIN RESEARCH, 1999, 848 (1-2) : A36 - A36
  • [5] JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-Hydroxydopamine Model of Parkinson's Disease
    Crocker, Candice E.
    Khan, Susan
    Cameron, Michael D.
    Robertson, Harold A.
    Robertson, George S.
    LoGrasso, Philip
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (04): : 207 - 212
  • [6] Is There a Rationale for Neuroprotection Against Dopamine Toxicity in Parkinson's Disease?
    Ari Barzilai
    Eldad Melamed
    Anat Shirvan
    Cellular and Molecular Neurobiology, 2001, 21 : 215 - 235
  • [7] Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?
    Barzilai, A
    Melamed, E
    Shirvan, A
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2001, 21 (03) : 215 - 235
  • [8] Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson's Disease Models
    Yang, Hanyu
    Wang, Lu
    Zang, Caixia
    Wang, Yue
    Shang, Junmei
    Zhang, Zihong
    Liu, Hui
    Bao, Xiuqi
    Wang, Xiaoliang
    Zhang, Dan
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [9] Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease
    Del Fabbro, Lucian
    Goes, Andre Rossito
    Jesse, Cristiano Ricardo
    de Gomes, Marcelo Gomes
    Souza, Leandro Cattelan
    Lobo Ladd, Fernando V.
    Lobo Ladd, Aliny A. B.
    Nunes Arantes, Ricardo Vinicius
    Simionato, Astor Reis
    Oliveira, Mauro Schneider
    Furian, Ana Flavia
    Boeira, Silvana Peterini
    NEUROSCIENCE LETTERS, 2019, 706 : 158 - 163
  • [10] Vasoactive intestinal peptide protects from dopamine toxicity: Relevance for Parkinson's disease.
    Melamed, M
    Sharki, J
    Offen, D
    Fridkin, M
    Brenneman, DE
    Gozes, I
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 458 - 459
12345